Arkolith/Insider Trading/TERN/Form 4

Quigley Jill M.

DirectorTerns Pharmaceuticals, Inc. (TERN) · full profile →Form 4 · filed Nov 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$441K
Net Open-Market Flow
-$441K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 4, 2025Sell(S)25K$18.00$441K0
Nov 4, 2025Option exercise(M)25K$9.24$227K25K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 4, 2025Option exercise(M)25K—$04K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001799780-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML